THU0028 Microrna-381 Ameliorates Arthritis by Controlling Functions of Fibroblast-like Synoviocytes, Which Are Affected by A To I RNA Editing
BackgroundMicroRNAs (miRNAs) play as regulators of rheumatoid arthritis (RA) and other diseases. MicroRNA is edited by the adenosine deaminase double-stranded RNA (ADAR) as well as mRNA and other noncoding RNA after transcription. A to I RNA editing is occurred limited variety of miRNAs. MicroRNA-38...
Gespeichert in:
Veröffentlicht in: | Annals of the rheumatic diseases 2016-06, Vol.75 (Suppl 2), p.187-187 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 187 |
---|---|
container_issue | Suppl 2 |
container_start_page | 187 |
container_title | Annals of the rheumatic diseases |
container_volume | 75 |
creator | Tanaka, Y. Takada, S. Iizasa, H. Hatzigeorgiou, A. Miyazawa, S.-I. Furumatsu, T. Nishida, K. Asahara, H. |
description | BackgroundMicroRNAs (miRNAs) play as regulators of rheumatoid arthritis (RA) and other diseases. MicroRNA is edited by the adenosine deaminase double-stranded RNA (ADAR) as well as mRNA and other noncoding RNA after transcription. A to I RNA editing is occurred limited variety of miRNAs. MicroRNA-381 (MiR-381) is one of limited miRNAs and was down regulated in synovium derived from patients with RA. However, the function of miR-381 and A to I RNA editing against RA is not clear.ObjectivesTo clarify a role of miR-381 and A to I RNA editing in synovium derived from RA or OA.Methods1) RNA was purified from the synovium derive from patients with RA (n=6) or OA (n=6) and analyzed with next generation sequencing (NGS). MiRNA editing was annotated containing 2 nucleotide mismatch. 2) The expression of wild type (WT) and edited miR-381 of synovium derived from RA (n=10) was compared to OA (n=10) with real time PCR. 3) Fibroblast-like synoviocytes (FLS) purified from RA synovium (n=3) were treated TNFα and IL-1β to clear miR-381 expression mechanism. 4) FLS were transfected with WT or edited miRNA expression vectors. These migration, proliferation and MMP production were analyzed. The target genes was predicted and determined by luciferase assay. 5) Male DBA/1 mice were intraperitoneally injected anti-collagen antibodies (collagen antibody-induced arthritis, CAIA) on day0 and LPS on day3. MiR-381 mimic was injected intra articular space on day0 and 3 after antibody injection. Arthritis was evaluated by arthritis score and histological score.Results1) Two types of A to I RNA editing were detected in miR-381 seed sequence using NGS (edit1/edit2). 2) These expression of both WT, edit1 and edit2 miR-381 in RA synovium were lower than OA (p |
doi_str_mv | 10.1136/annrheumdis-2016-eular.2299 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1901813948</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4322509945</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1278-aecd71f182db9f723f008fea73f59e30b08434ed1ca4cafbeecdf2c3094479fa3</originalsourceid><addsrcrecordid>eNqVkbFOwzAQhi0EEqXwDpZYSbHjkNhiiqqWViogQStGy3Hs1iW1wU6QurEw8448CS5lYGU63en__9PdB8A5RgOMSX4prPUr1W1qE5IU4TxRXSP8IE0ZOwA9nOU0jnN0CHoIIZJkLC-OwUkI69giimkPfM4nC4RS-vX-cWukd96KhFAMy41qjPOiVQGWvl1505oAqy0cOtt61zTGLuG4s7I1zgboNBybyruqEaFNGvOs4OPWujfj5DZGXMCnlZGrmKRgqbWSrap3YSWcOziFD3clHNVxg12egiMtmqDOfmsfLMaj-XCSzO5vpsNyllQ4LWgilKwLrDFN64rpIiU63qOVKIi-YoqgCtGMZKrGUmRS6EpFvU4lQSzLCqYF6YPzfe6Ld6-dCi1fuy4e3wSOGcIUE5bRqLreq-JnQvBK8xdvNsJvOUZ8R4D_IcB3BPgPAb4jEN353l1t1v8yfgP9a5Py</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1901813948</pqid></control><display><type>article</type><title>THU0028 Microrna-381 Ameliorates Arthritis by Controlling Functions of Fibroblast-like Synoviocytes, Which Are Affected by A To I RNA Editing</title><source>BMJ Journals - NESLi2</source><creator>Tanaka, Y. ; Takada, S. ; Iizasa, H. ; Hatzigeorgiou, A. ; Miyazawa, S.-I. ; Furumatsu, T. ; Nishida, K. ; Asahara, H.</creator><creatorcontrib>Tanaka, Y. ; Takada, S. ; Iizasa, H. ; Hatzigeorgiou, A. ; Miyazawa, S.-I. ; Furumatsu, T. ; Nishida, K. ; Asahara, H.</creatorcontrib><description>BackgroundMicroRNAs (miRNAs) play as regulators of rheumatoid arthritis (RA) and other diseases. MicroRNA is edited by the adenosine deaminase double-stranded RNA (ADAR) as well as mRNA and other noncoding RNA after transcription. A to I RNA editing is occurred limited variety of miRNAs. MicroRNA-381 (MiR-381) is one of limited miRNAs and was down regulated in synovium derived from patients with RA. However, the function of miR-381 and A to I RNA editing against RA is not clear.ObjectivesTo clarify a role of miR-381 and A to I RNA editing in synovium derived from RA or OA.Methods1) RNA was purified from the synovium derive from patients with RA (n=6) or OA (n=6) and analyzed with next generation sequencing (NGS). MiRNA editing was annotated containing 2 nucleotide mismatch. 2) The expression of wild type (WT) and edited miR-381 of synovium derived from RA (n=10) was compared to OA (n=10) with real time PCR. 3) Fibroblast-like synoviocytes (FLS) purified from RA synovium (n=3) were treated TNFα and IL-1β to clear miR-381 expression mechanism. 4) FLS were transfected with WT or edited miRNA expression vectors. These migration, proliferation and MMP production were analyzed. The target genes was predicted and determined by luciferase assay. 5) Male DBA/1 mice were intraperitoneally injected anti-collagen antibodies (collagen antibody-induced arthritis, CAIA) on day0 and LPS on day3. MiR-381 mimic was injected intra articular space on day0 and 3 after antibody injection. Arthritis was evaluated by arthritis score and histological score.Results1) Two types of A to I RNA editing were detected in miR-381 seed sequence using NGS (edit1/edit2). 2) These expression of both WT, edit1 and edit2 miR-381 in RA synovium were lower than OA (p<0.05). 3) The expression of series of miR-381s were decreased by TNFα and IL-1β stimulation. 4) Overexpression of WT and edit1 miR-381 reduced the migration of FLS (p<0.01). Overexpression of edit1 and 2 miR-381 repressed proliferation of FLS (p<0.01), which may be caused by reducing CUL3 mRNA expression. CUL3 was regulator of cell cycle and was a direct target gene of edited miR-381s by luciferase assay. All types of miR-381 reduced MMP13 expression (p<0.05). 5) Treatment with miR-381 mimic increased expression of miR-381 in synovium but not in other tissues and significantly reduced arthritis score (scramble vs. miR-381 mimic: 11.5±0.76 vs. 8.4±2.06) and cartilage destruction.ConclusionsThese findings suggested that miR-381 was added functions by A to I RNA editing and controls FLS and arthritis.Disclosure of InterestY. Tanaka Grant/research support from: Resesarch Fellow of Japan Society for the Promotion of Science, S. Takada Grant/research support from: CREST, Japan Science and Technology Agency, H. Iizasa: None declared, A. Hatzigeorgiou: None declared, S.-I. Miyazawa: None declared, T. Furumatsu: None declared, K. Nishida: None declared, H. Asahara Grant/research support from: CREST, Japan Science and Technology Agency</description><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/annrheumdis-2016-eular.2299</identifier><identifier>CODEN: ARDIAO</identifier><language>eng</language><publisher>London: BMJ Publishing Group LTD</publisher><ispartof>Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.187-187</ispartof><rights>2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2016 (c) 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://ard.bmj.com/content/75/Suppl_2/187.2.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://ard.bmj.com/content/75/Suppl_2/187.2.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,780,784,3196,23571,27924,27925,77600,77631</link.rule.ids></links><search><creatorcontrib>Tanaka, Y.</creatorcontrib><creatorcontrib>Takada, S.</creatorcontrib><creatorcontrib>Iizasa, H.</creatorcontrib><creatorcontrib>Hatzigeorgiou, A.</creatorcontrib><creatorcontrib>Miyazawa, S.-I.</creatorcontrib><creatorcontrib>Furumatsu, T.</creatorcontrib><creatorcontrib>Nishida, K.</creatorcontrib><creatorcontrib>Asahara, H.</creatorcontrib><title>THU0028 Microrna-381 Ameliorates Arthritis by Controlling Functions of Fibroblast-like Synoviocytes, Which Are Affected by A To I RNA Editing</title><title>Annals of the rheumatic diseases</title><description>BackgroundMicroRNAs (miRNAs) play as regulators of rheumatoid arthritis (RA) and other diseases. MicroRNA is edited by the adenosine deaminase double-stranded RNA (ADAR) as well as mRNA and other noncoding RNA after transcription. A to I RNA editing is occurred limited variety of miRNAs. MicroRNA-381 (MiR-381) is one of limited miRNAs and was down regulated in synovium derived from patients with RA. However, the function of miR-381 and A to I RNA editing against RA is not clear.ObjectivesTo clarify a role of miR-381 and A to I RNA editing in synovium derived from RA or OA.Methods1) RNA was purified from the synovium derive from patients with RA (n=6) or OA (n=6) and analyzed with next generation sequencing (NGS). MiRNA editing was annotated containing 2 nucleotide mismatch. 2) The expression of wild type (WT) and edited miR-381 of synovium derived from RA (n=10) was compared to OA (n=10) with real time PCR. 3) Fibroblast-like synoviocytes (FLS) purified from RA synovium (n=3) were treated TNFα and IL-1β to clear miR-381 expression mechanism. 4) FLS were transfected with WT or edited miRNA expression vectors. These migration, proliferation and MMP production were analyzed. The target genes was predicted and determined by luciferase assay. 5) Male DBA/1 mice were intraperitoneally injected anti-collagen antibodies (collagen antibody-induced arthritis, CAIA) on day0 and LPS on day3. MiR-381 mimic was injected intra articular space on day0 and 3 after antibody injection. Arthritis was evaluated by arthritis score and histological score.Results1) Two types of A to I RNA editing were detected in miR-381 seed sequence using NGS (edit1/edit2). 2) These expression of both WT, edit1 and edit2 miR-381 in RA synovium were lower than OA (p<0.05). 3) The expression of series of miR-381s were decreased by TNFα and IL-1β stimulation. 4) Overexpression of WT and edit1 miR-381 reduced the migration of FLS (p<0.01). Overexpression of edit1 and 2 miR-381 repressed proliferation of FLS (p<0.01), which may be caused by reducing CUL3 mRNA expression. CUL3 was regulator of cell cycle and was a direct target gene of edited miR-381s by luciferase assay. All types of miR-381 reduced MMP13 expression (p<0.05). 5) Treatment with miR-381 mimic increased expression of miR-381 in synovium but not in other tissues and significantly reduced arthritis score (scramble vs. miR-381 mimic: 11.5±0.76 vs. 8.4±2.06) and cartilage destruction.ConclusionsThese findings suggested that miR-381 was added functions by A to I RNA editing and controls FLS and arthritis.Disclosure of InterestY. Tanaka Grant/research support from: Resesarch Fellow of Japan Society for the Promotion of Science, S. Takada Grant/research support from: CREST, Japan Science and Technology Agency, H. Iizasa: None declared, A. Hatzigeorgiou: None declared, S.-I. Miyazawa: None declared, T. Furumatsu: None declared, K. Nishida: None declared, H. Asahara Grant/research support from: CREST, Japan Science and Technology Agency</description><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqVkbFOwzAQhi0EEqXwDpZYSbHjkNhiiqqWViogQStGy3Hs1iW1wU6QurEw8448CS5lYGU63en__9PdB8A5RgOMSX4prPUr1W1qE5IU4TxRXSP8IE0ZOwA9nOU0jnN0CHoIIZJkLC-OwUkI69giimkPfM4nC4RS-vX-cWukd96KhFAMy41qjPOiVQGWvl1505oAqy0cOtt61zTGLuG4s7I1zgboNBybyruqEaFNGvOs4OPWujfj5DZGXMCnlZGrmKRgqbWSrap3YSWcOziFD3clHNVxg12egiMtmqDOfmsfLMaj-XCSzO5vpsNyllQ4LWgilKwLrDFN64rpIiU63qOVKIi-YoqgCtGMZKrGUmRS6EpFvU4lQSzLCqYF6YPzfe6Ld6-dCi1fuy4e3wSOGcIUE5bRqLreq-JnQvBK8xdvNsJvOUZ8R4D_IcB3BPgPAb4jEN353l1t1v8yfgP9a5Py</recordid><startdate>201606</startdate><enddate>201606</enddate><creator>Tanaka, Y.</creator><creator>Takada, S.</creator><creator>Iizasa, H.</creator><creator>Hatzigeorgiou, A.</creator><creator>Miyazawa, S.-I.</creator><creator>Furumatsu, T.</creator><creator>Nishida, K.</creator><creator>Asahara, H.</creator><general>BMJ Publishing Group LTD</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>201606</creationdate><title>THU0028 Microrna-381 Ameliorates Arthritis by Controlling Functions of Fibroblast-like Synoviocytes, Which Are Affected by A To I RNA Editing</title><author>Tanaka, Y. ; Takada, S. ; Iizasa, H. ; Hatzigeorgiou, A. ; Miyazawa, S.-I. ; Furumatsu, T. ; Nishida, K. ; Asahara, H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1278-aecd71f182db9f723f008fea73f59e30b08434ed1ca4cafbeecdf2c3094479fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tanaka, Y.</creatorcontrib><creatorcontrib>Takada, S.</creatorcontrib><creatorcontrib>Iizasa, H.</creatorcontrib><creatorcontrib>Hatzigeorgiou, A.</creatorcontrib><creatorcontrib>Miyazawa, S.-I.</creatorcontrib><creatorcontrib>Furumatsu, T.</creatorcontrib><creatorcontrib>Nishida, K.</creatorcontrib><creatorcontrib>Asahara, H.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tanaka, Y.</au><au>Takada, S.</au><au>Iizasa, H.</au><au>Hatzigeorgiou, A.</au><au>Miyazawa, S.-I.</au><au>Furumatsu, T.</au><au>Nishida, K.</au><au>Asahara, H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>THU0028 Microrna-381 Ameliorates Arthritis by Controlling Functions of Fibroblast-like Synoviocytes, Which Are Affected by A To I RNA Editing</atitle><jtitle>Annals of the rheumatic diseases</jtitle><date>2016-06</date><risdate>2016</risdate><volume>75</volume><issue>Suppl 2</issue><spage>187</spage><epage>187</epage><pages>187-187</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><coden>ARDIAO</coden><abstract>BackgroundMicroRNAs (miRNAs) play as regulators of rheumatoid arthritis (RA) and other diseases. MicroRNA is edited by the adenosine deaminase double-stranded RNA (ADAR) as well as mRNA and other noncoding RNA after transcription. A to I RNA editing is occurred limited variety of miRNAs. MicroRNA-381 (MiR-381) is one of limited miRNAs and was down regulated in synovium derived from patients with RA. However, the function of miR-381 and A to I RNA editing against RA is not clear.ObjectivesTo clarify a role of miR-381 and A to I RNA editing in synovium derived from RA or OA.Methods1) RNA was purified from the synovium derive from patients with RA (n=6) or OA (n=6) and analyzed with next generation sequencing (NGS). MiRNA editing was annotated containing 2 nucleotide mismatch. 2) The expression of wild type (WT) and edited miR-381 of synovium derived from RA (n=10) was compared to OA (n=10) with real time PCR. 3) Fibroblast-like synoviocytes (FLS) purified from RA synovium (n=3) were treated TNFα and IL-1β to clear miR-381 expression mechanism. 4) FLS were transfected with WT or edited miRNA expression vectors. These migration, proliferation and MMP production were analyzed. The target genes was predicted and determined by luciferase assay. 5) Male DBA/1 mice were intraperitoneally injected anti-collagen antibodies (collagen antibody-induced arthritis, CAIA) on day0 and LPS on day3. MiR-381 mimic was injected intra articular space on day0 and 3 after antibody injection. Arthritis was evaluated by arthritis score and histological score.Results1) Two types of A to I RNA editing were detected in miR-381 seed sequence using NGS (edit1/edit2). 2) These expression of both WT, edit1 and edit2 miR-381 in RA synovium were lower than OA (p<0.05). 3) The expression of series of miR-381s were decreased by TNFα and IL-1β stimulation. 4) Overexpression of WT and edit1 miR-381 reduced the migration of FLS (p<0.01). Overexpression of edit1 and 2 miR-381 repressed proliferation of FLS (p<0.01), which may be caused by reducing CUL3 mRNA expression. CUL3 was regulator of cell cycle and was a direct target gene of edited miR-381s by luciferase assay. All types of miR-381 reduced MMP13 expression (p<0.05). 5) Treatment with miR-381 mimic increased expression of miR-381 in synovium but not in other tissues and significantly reduced arthritis score (scramble vs. miR-381 mimic: 11.5±0.76 vs. 8.4±2.06) and cartilage destruction.ConclusionsThese findings suggested that miR-381 was added functions by A to I RNA editing and controls FLS and arthritis.Disclosure of InterestY. Tanaka Grant/research support from: Resesarch Fellow of Japan Society for the Promotion of Science, S. Takada Grant/research support from: CREST, Japan Science and Technology Agency, H. Iizasa: None declared, A. Hatzigeorgiou: None declared, S.-I. Miyazawa: None declared, T. Furumatsu: None declared, K. Nishida: None declared, H. Asahara Grant/research support from: CREST, Japan Science and Technology Agency</abstract><cop>London</cop><pub>BMJ Publishing Group LTD</pub><doi>10.1136/annrheumdis-2016-eular.2299</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-4967 |
ispartof | Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.187-187 |
issn | 0003-4967 1468-2060 |
language | eng |
recordid | cdi_proquest_journals_1901813948 |
source | BMJ Journals - NESLi2 |
title | THU0028 Microrna-381 Ameliorates Arthritis by Controlling Functions of Fibroblast-like Synoviocytes, Which Are Affected by A To I RNA Editing |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T04%3A11%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=THU0028%E2%80%85Microrna-381%20Ameliorates%20Arthritis%20by%20Controlling%20Functions%20of%20Fibroblast-like%20Synoviocytes,%20Which%20Are%20Affected%20by%20A%20To%20I%20RNA%20Editing&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=Tanaka,%20Y.&rft.date=2016-06&rft.volume=75&rft.issue=Suppl%202&rft.spage=187&rft.epage=187&rft.pages=187-187&rft.issn=0003-4967&rft.eissn=1468-2060&rft.coden=ARDIAO&rft_id=info:doi/10.1136/annrheumdis-2016-eular.2299&rft_dat=%3Cproquest_cross%3E4322509945%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1901813948&rft_id=info:pmid/&rfr_iscdi=true |